CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,383 | +266.6% | 590,067 | +306.0% | 0.01% | +233.3% |
| Q2 2023 | $4,742 | -60.5% | 145,346 | -57.4% | 0.00% | -50.0% |
| Q1 2023 | $12,009 | -34.0% | 341,272 | -14.1% | 0.01% | -25.0% |
| Q4 2022 | $18,198 | -99.9% | 397,187 | -1.0% | 0.01% | -61.9% |
| Q3 2022 | $19,441,000 | +50.7% | 401,253 | +22.2% | 0.02% | +162.5% |
| Q2 2022 | $12,898,000 | +331.4% | 328,281 | +304.4% | 0.01% | +300.0% |
| Q1 2022 | $2,990,000 | -68.9% | 81,177 | -61.6% | 0.00% | 0.0% |
| Q4 2021 | $9,626,000 | +223.5% | 211,178 | +153.5% | 0.00% | +100.0% |
| Q3 2021 | $2,976,000 | +182.9% | 83,294 | +56.7% | 0.00% | – |
| Q2 2021 | $1,052,000 | -66.7% | 53,141 | -60.9% | 0.00% | -100.0% |
| Q1 2021 | $3,163,000 | -17.9% | 135,887 | -26.7% | 0.00% | 0.0% |
| Q4 2020 | $3,851,000 | -11.2% | 185,332 | -7.5% | 0.00% | -33.3% |
| Q3 2020 | $4,337,000 | +38.0% | 200,295 | +50.3% | 0.00% | +50.0% |
| Q2 2020 | $3,142,000 | +444.5% | 133,307 | +172.6% | 0.00% | – |
| Q1 2020 | $577,000 | -37.6% | 48,910 | -43.8% | 0.00% | -100.0% |
| Q4 2019 | $924,000 | -27.4% | 87,091 | -22.1% | 0.00% | 0.0% |
| Q3 2019 | $1,272,000 | +74.0% | 111,742 | +72.0% | 0.00% | – |
| Q2 2019 | $731,000 | +166.8% | 64,959 | +92.0% | 0.00% | – |
| Q1 2019 | $274,000 | +89.0% | 33,831 | +46.8% | 0.00% | – |
| Q4 2018 | $145,000 | -73.7% | 23,049 | -58.8% | 0.00% | – |
| Q3 2018 | $552,000 | +173.3% | 56,001 | +130.2% | 0.00% | – |
| Q2 2018 | $202,000 | +18.1% | 24,332 | +3.1% | 0.00% | – |
| Q1 2018 | $171,000 | +8.9% | 23,611 | +22.4% | 0.00% | – |
| Q4 2017 | $157,000 | -83.6% | 19,297 | -70.8% | 0.00% | -100.0% |
| Q3 2017 | $957,000 | +223.3% | 66,003 | +169.8% | 0.00% | – |
| Q2 2017 | $296,000 | +211.6% | 24,466 | +230.5% | 0.00% | – |
| Q1 2017 | $95,000 | -48.9% | 7,402 | -51.7% | 0.00% | – |
| Q4 2016 | $186,000 | +93.8% | 15,324 | +47.6% | 0.00% | – |
| Q3 2016 | $96,000 | +31.5% | 10,380 | +34.6% | 0.00% | – |
| Q2 2016 | $73,000 | +37.7% | 7,714 | +1.0% | 0.00% | – |
| Q1 2016 | $53,000 | +5200.0% | 7,638 | +5867.2% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 128 | -29.7% | 0.00% | – |
| Q3 2015 | $1,000 | -80.0% | 182 | -76.0% | 0.00% | – |
| Q2 2015 | $5,000 | -81.5% | 759 | -82.6% | 0.00% | – |
| Q1 2015 | $27,000 | -35.7% | 4,355 | -17.5% | 0.00% | – |
| Q4 2014 | $42,000 | -59.6% | 5,278 | -84.9% | 0.00% | – |
| Q3 2014 | $104,000 | +5100.0% | 34,920 | +6135.7% | 0.00% | – |
| Q2 2014 | $2,000 | -99.7% | 560 | -99.4% | 0.00% | -100.0% |
| Q1 2014 | $799,000 | +26533.3% | 88,763 | +14944.6% | 0.00% | – |
| Q4 2013 | $3,000 | -50.0% | 590 | -32.3% | 0.00% | – |
| Q3 2013 | $6,000 | – | 871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |